The quadruple screening test, also referred to as the quadruple marker test, is a routine blood test administered between 14 and 20 weeks of pregnancy. Its primary purpose is to assess the likelihood of certain genetic conditions in the fetus.
Pioneers in Prenatal Care
Medicover Hospitals provides comprehensive prenatal care in the second trimester, including the Quadruple Screening Test and other screenings. With advanced genetic labs using next-gen sequencing, we deliver precise results. Trust us for the best Quadruple Screening Test near you, ensuring peace of mind for expectant parents.
What Does It Screen For?
This test evaluates four biochemical markers to estimate the probability of various conditions, including Down syndrome, Trisomy 18, Edwards syndrome, neural tube defects, and abdominal wall defects.
How Quadruple Screening Test Works
The quadruple screening test doesn't provide a diagnosis but helps identify any potential increased risk of congenital disorders. If the results are abnormal, further diagnostic tests may be recommended.
Procedure and Timing
The test, performed by a phlebotomist, involves a simple blood draw from the expectant mother. For the most accurate results, it's typically conducted between weeks 16 and 18 of pregnancy.
Process Overview
Medicover ensures a seamless process from sample collection to genetic counseling, empowering parents with accurate information. With advanced prenatal screening, we prioritize the well-being of both mothers and their unborn children.
Why choose Medicover Hospitals
0
+ Expert Doctors
0
+ Bedded Level 4 NICU
0
K+ Happy Patients
0
+ Beds FacilityFrequently Asked Questions
What if a quadruple test is positive?
A quadruple test, also known as a quad screen, indicates a fetus's risk of congenital diseases. A positive result doesn't necessarily mean a birth defect; a typical result indicates a low risk, although not necessarily free of issues.
Is a quadruple test necessary in pregnancy?
The quadruple marker test, a blood test examining four chemicals, is recommended for individuals with risk factors for chromosomal abnormalities or neural tube defects, typically conducted between the 15th and 22nd week of pregnancy.
What is the normal report of the test?
A normal triple marker test indicates a lower likelihood of congenital impairments in a fetus. However, this may not always be the case, and the typical range for quadruple markers varies between laboratories.
What does the test include?
A quadruple screening test is a blood test used to determine the levels of four pregnancy hormones: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. These hormones are expressed by the infant and produced in the placenta.
